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Abstract We report the first Fourier transform infrared
analysis of prion protein (PrP) repeats and the first study of
PrP repeats of marsupial origin. Large changes in the secondary
structure and an increase in hydrogen bonding within the peptide
groups were evident from a red shift of the amide I band by s 7
cm31 and an approximately five-fold reduction in amide
hydrogen^deuterium exchange for peptide interacting with
Cu2+ ions. Changes in the tertiary structure upon copper binding
were also evident from the appearance of a new band at 1564
cm31, which arises from the ring vibration of histidine. The
copper-induced conformational change is pH dependent, and
occurs at pH s 7. ß 2002 Federation of European Microbio-
logical Societies. Published by Elsevier Science B.V. All rights
reserved.
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1. Introduction
Prion diseases are fatal neurodegenerative disorders associ-
ated with abnormal metabolism of prion protein (PrP) [1]. PrP
is a cell-surface protein with unclear functions, which is nor-
mally present in a soluble form, PrPC. In diseased animals, an
infectious aggregated form, PrPSc, is observed, which is com-
posed largely, if not entirely, of an alternative conformer of
PrP [1]. This identi¢cation with conformational diseases [2,3]
has lead to intensive investigation of the properties of PrP
using structural [4^7] and biophysical approaches [3,8].
Although relatively short (V253 residues, mammalian), the
sequence of PrP is unusual in that it contains a number of
regions with quite di¡erent amino acid compositions [9] and
apparent structure. Solution nuclear magnetic resonance
(NMR) structures of several full-length mammalian PrPs
show that the N-terminal region (residues 23^125), including
the PGH-rich tandem repeats (residues 60^91), are unstruc-
tured, while the C-terminal region (residues 126^231) adopts a
loosely folded structure containing three K-helices and two
short L-strands [4^7]. Mammalian PrPs have ¢ve tandem oc-
tapeptide repeats with the consensus sequence PHGGGWGQ
[9].
Of the several functions ascribed to PrP, some ¢ndings
suggest a role in copper metabolism [10^12] associated with
binding to the N-terminal region at physiological copper con-
centrations [13,14]. Interestingly, although this region of PrP
is not essential for pathogenesis, it modulates the extent and
timing of disease presentation [15], and it has been suggested
that copper may also have a role in the disease [16]. Recently,
copper binding to the C-terminal domain at pHs 6 6 only
[17], and to the region between the repeats and C-terminal
region (92^125) [18,19] has been shown. Studies using re-
combinant full-length protein, as well as synthetic peptides
containing the N-terminal repeats, show preferential binding
of copper over other metals [14,19^21].
Various biophysical methods have been applied to study the
structure of the repeat region of PrP in the presence and
absence of copper [14,19^29]. These have used a range of
synthetic and cloned peptides containing di¡erent numbers
of repeats with either consensus [20^22,24,26^28] or actual
[19,22,23,25,29] sequences from mammals or chicken, or
full-length mammalian protein [14]. The possibility of an ef-
fect on repeat-region conformation from peptide length and
sequence, particularly from use of designed (multiple-consen-
sus) sequences or authentic sequences covering only part of
the N-terminal region of PrP, needs to be considered. How-
ever, the fact that there is considerable natural variability in
repeat sequence from the consensus, suggests that critical fea-
tures of the conformational changes may be relatively insen-
sitive to the exact repeat sequence or its environment. The
biophysical studies have yielded variable results for the struc-
tural changes, as well as the stoichiometry and strength of
copper binding, which may be due to a variety of experimen-
tal factors apart from peptide di¡erences: pH dependence,
bu¡er artifacts, solubility problems for both protein and cop-
per and their complexes at pH s 7, and di¡erent concentra-
tion ranges for the analytical methods [17]. In the absence of
copper, CD [21,23^25] and Raman [22,26] spectroscopies, as
well as NMR [4^7] have shown that the repeat region is un-
structured. However, another CD study reports the presence
of non-random structure similar to the poly-L-proline type II
left-handed helix [27], while a recent NMR study suggests
certain residues within the repeats adopt loop and L-turn
structure [28]. Also, copper binding to octarepeat peptides
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has been reported to induce the formation of K-helical struc-
ture as probed by Raman spectroscopy [22,26], in disagree-
ment with one CD study which suggests no structural changes
upon addition of copper [20]. Yet other CD experiments sug-
gested the presence of turns and structured loop resulting
from copper addition to repeat peptides [23^25].
Of available methods, Fourier transform infrared (FTIR)
spectroscopy has not so far been used to probe the conforma-
tional changes of PrP repeats upon interaction with copper.
FTIR spectroscopy is a well-established technique for the con-
formational analysis of peptides and proteins [30]. Informa-
tion on the secondary structure of peptides can be derived
from analysis of the strong amide I band, which arises pri-
marily from the CNO stretching vibration of the amide
group. Here we report the ¢rst FTIR spectroscopic analysis
of the tandem repeats of a PrP. This is also the ¢rst biophys-
ical characterization of a region of a marsupial PrP. Only one
amino acid sequence of a marsupial PrP has been reported,
that for brush-tailed possum [31]. It contains the four-repeat
sequence PQGGGTNWGQ PHPGGSNWGQ PHPGGSS-
WGQ PHGGSNWGQ within the N-terminal repeat region,
i.e. all with di¡erent 9- or 10-residue sequences. In the absence
of other marsupial sequences which might reveal a dominant
marsupial consensus, we chose to synthesize a peptide con-
taining three copies of the second-repeat sequence
[(PHPGGSNWGQ)3G; Msp3]. This contains the apparently
dominant 10-residue marsupial repeat and, as for the third
repeat, most resembles the eight-residue consensus motif of
mammals (PHGGGWGQ). But, interestingly, it has two addi-
tional polar residues (SN) in the middle of the repeat which
are similarly present in the other three repeats of possum PrP.
We report the conformational properties of Msp3 in the pres-
ence and absence of copper, probed using FTIR spectroscopy.
As copper binding has been proposed to involve histidine
residues of the PrP repeat [14,18,23,24,29], we have also in-
vestigated the copper binding properties of the model di-his-
tidine peptide using FTIR.
2. Materials and methods
2.1. Chemicals
Copper (II) chloride was analytical grade and purchased from Sig-
ma.
2.2. Peptide synthesis
Synthetic peptide (PHPGGSNWGQ)3G (Msp3) was supplied by
the Biomolecular Resources Facility at the John Curtin School of
Medical Research, the Australian National University, Canberra,
ACT, Australia. The peptide was synthesized using the Applied Bio-
systems 430A Peptide Synthesizer with the 9-£uorenyl methoxycar-
bonyl method. Cleavage of the peptide from the resin was performed
in a mixture of 10 ml tri£uoroacetic acid (TFA), 0.5 ml H2O, 0.75 g
phenol, 0.5 ml thioanisole, and 0.25 ml ethanedithiol. The crude pep-
tide was puri¢ed by Bio-Rad high-performance liquid chromatogra-
phy on a C18 column, using a 4^40% linear gradient of acetonitrile in
0.09% (v/v) TFA. The peptide was then freeze dried.
2.3. Sample preparation
In order to remove residual TFA, the peptide was further puri¢ed
by mini-column chromatography, using anion exchange resin (amber-
lite IR-45). The column was pre-equilibrated with bidistilled water.
The peptide was dissolved in 1 ml of bidistilled water and transferred
to the column, which was then eluted with bidistilled water. Collected
fractions were freeze dried [32]. UV/vis spectrophotometry was used
to check the peptide concentration based on tryptophan absorption at
280 nm (O280 = 5500 M31 cm31). In order to avoid copper precipita-
tion as copper hydroxide at pHs above 6 [10], the sample was pre-
pared according to the method of Takeuchi (personal communica-
tion), with some modi¢cations. The Msp3 solution was basi¢ed to
about pH 12 by addition of NaOH, and then CuCl2 solution was
added. The pH was adjusted to the desired pH by addition of HCl.
The solution was freeze dried and redissolved in 2H2O. In the ¢nal
solution, the concentrations of Msp3 and CuCl2 were 5 and 20 mM,
respectively. For the di-histidine peptide, the concentrations of di-
histidine and CuCl2 were 40 and 10 mM, respectively.
2.4. Infrared spectroscopic measurements and analysis
Infrared spectra were recorded on a Perkin Elmer Spectrum One
Fourier Transform Infrared spectrometer. Samples were placed in a
micro cell ¢tted with CaF2 windows and a 50 Wm te£on spacer. 400
scans at resolution 4 cm31 were taken and signal averaged. FTIR
spectra were recorded in 2H2O and not H2O to avoid the strong
interference of water absorbance in the amide I region. Use of
2H2O also allows use of longer-path-length cells to obtain higher
signal to noise ratio. Also, measurement in 2H2O allows monitoring
of the hydrogen^deuterium (H^D) exchange process [30,33,34] in cop-
per-free and copper-bound forms of the peptide. Spectra were re-
corded at 25‡C and the sample compartment was continuously purged
with nitrogen gas to suppress water vapor absorbance in the spectral
region of interest. Data were analyzed using the Spectrum v.3.00
software from Perkin Elmer. Subtraction of the 2H2O spectrum
from the sample spectrum was carried out digitally to give a straight
baseline in the region 2000^1800 cm31 (see [33]). The resulting absor-
bance spectrum of the peptide was analyzed using the second-deriva-
tive procedure with a 13 data point Savitzky-Golay smoothing win-
dow [33]. H^D exchange was measured by monitoring the change in
the intensity of the amide II band as a function of time [33,34].
Fig. 1. E¡ect of copper addition on the FTIR spectrum of the Msp3 peptide. Absorbance (A) and second-derivative (B) spectra of the Msp3
(PHPGGSNWGQ)3G peptide in 2H2O at pH 8, recorded in the absence (top) and presence (bottom) of 20 mM CuCl2. The peptide concentra-
tion used for these measurements is 5 mM. The asterisks indicate the appearance of a new band upon addition of copper.
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3. Results and discussion
Fig. 1 compares the FTIR spectra of the Msp3 peptide
recorded in the presence and absence of copper at pH 8.
Analysis of the absorbance spectra (Fig. 1A) reveals that the
amide I maximum shifts from 1646 cm31 to 1639 cm31 upon
addition of copper. An additional di¡erence between the two
spectra is the appearance of a new band at 1564 cm31 for the
peptide in the presence of copper. Detailed analysis using the
second-derivative procedure was also performed (Fig. 1B).
Other than the appearance of a shoulder near 1670 cm31,
the second-derivative analysis (Fig. 1B) con¢rms what can
be seen from the absorbance spectra (Fig. 1A).
The amide I maximum at 1646 cm31 for the copper-free
form of the peptide in 2H2O can be attributed to random-
coil structure. The presence of random-coil structure has been
reported for other PrP repeat peptides, in the absence of cop-
per, using various biophysical techniques including Raman
spectroscopy [21^26]. The assignment of the band at 1639
cm31 in the copper-bound form of the peptide is complicated
as absorbance in this region can arise from L-sheet and L-turn
structures, as well as from solvent-exposed K-helices [30].
However, an increase in ordered secondary structure, in the
presence of copper, is indicated by the fact that the amide I
band shifts toward lower frequency, re£ecting an increase in
hydrogen bonding. Although the assignment of this band is
not straightforward, it is possible that it re£ects solvent-ex-
posed K-helical structure. This assignment would be in good
agreement with the Raman spectroscopic measurements of
Miura et al. [22,26], who detected an increase in helix content
upon interaction of copper ions with a human PrP repeat
peptide.
Besides the large change in the amide I band frequency, the
appearance of an additional band near 1564 cm31 suggests a
change in peptide tertiary structure upon copper binding. In
order to identify the origin of this band, FTIR measurements
were performed with di-histidine peptides in the presence and
absence of copper (Fig. 2). The major di¡erence between the
two spectra is the appearance of a new band near 1566 cm31,
in the presence of copper. This band occurs at a similar band
frequency to that observed with the Msp3 peptide in the pres-
ence of copper. As the 1566 cm31 band appears upon addition
of copper, it can be ascribed to the copper-bound form of
histidine. This suggests the band observed at a virtually iden-
tical position in the spectrum of the copper-bound form of the
Msp3 peptide can also be attributed to the ring vibration of
the histidine residue when it is bound to copper.
In order to investigate the e¡ect of pH on the peptide
structure, FTIR spectra were recorded at di¡erent pH values,
ranging from 6 to 10, in the presence and absence of copper.
The results show no signi¢cant pH-induced changes in the
structure of the peptide in the absence of copper (Fig. 3).
The amide I band frequency is centered at 1644 cm31
throughout the pH range studied. However, in the presence
of copper, the spectrum of the peptide recorded at acidic pH
displays a band frequency of 1646 cm31 which shifts to 1639
cm31 at alkaline pH (s 7). Furthermore, a new band at 1564
cm31, as discussed above, is also observed. This change is
associated with interaction of copper ions with the peptide,
which appears to occur at alkaline pH.
It has been suggested previously that at pH 6 6 no binding
between the peptide and copper ions occurs [23,24,26]. It is,
Fig. 2. E¡ect of copper addition on the FTIR spectrum of the di-
histidine peptide. Absorbance spectra of di-histidine at 40 mM con-
centration recorded in 2H2O at pH 8 in the absence (top) and pres-
ence (bottom) of 10 mM CuCl2. The asterisk indicates the appear-
ance of a new band upon addition of copper.
Fig. 3. E¡ect of pH on the FTIR spectrum of Msp3 and the copper-complex of Msp3. Absorbance spectra of Msp3, (PHPGGSNWGQ)3G
peptide in 2H2O at 5 mM peptide concentration in the absence (A) and presence (B) of 20 mM CuCl2, at pH 6 (top) and pH 8 (bottom). The
asterisk indicates the appearance of a new band upon addition of copper.
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therefore, not surprising that the amide I band for the peptide
at pH 6 is observed at 1646 cm31 (a frequency similar to that
observed for the metal-free peptide), even though CuCl2 is
present. Furthermore, the 1564 cm31 band is absent at this
pH, which links the appearance of this band to the binding of
copper to the peptide. These observations additionally con-
¢rm that the spectral changes observed at alkaline pH values
re£ect conformational changes associated with binding of cop-
per. The amide I band positions for copper-bound peptide at
pHs 10, 9, and 8 are virtually identical, suggesting that in-
creasing the pH has no e¡ect on the structure of the copper-
bound form of the peptide. This is also evident from the fact
that the peptide in the absence of copper shows virtually no
change in the amide I band position as the pH is raised from 6
to 10.
FTIR spectroscopy is a particularly valuable tool for mon-
itoring H^D exchange properties of peptides and proteins
[30,33,34]. This can be done through monitoring the reduction
in the intensity of the amide II band as a function of time in
2H2O [30,33,34]. In this study we compared the H^D ex-
change rate of the Msp3 peptide in the presence and absence
of copper (Fig. 4). From these measurements we ¢nd that in
the presence of copper the H^D exchange rate is reduced by
approximately ¢ve-fold compared with that for the peptide in
the absence of copper. This suggests that the copper-bound
peptide has a more rigid, solvent inaccessible structure. This is
highly likely as we have observed that copper binding results
in a more strongly H-bonded structure, re£ected by a shift in
the frequency of the amide I band towards lower frequency.
The combination of the amide I band analysis and H^D ex-
change measurement further strengthens our suggestion that
copper binding results in an increase in ordered secondary
structure.
To conclude, the results of our FTIR spectroscopic analysis
reveal large changes in the secondary and tertiary structure of
a marsupial PrP repeat peptide associated with the binding of
copper. Copper binding results in a more strongly H-bonded
structure that has a signi¢cantly reduced solvent accessibility
compared with the copper-free form of the peptide.
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